The last day of the IGCS Annual Global Meeting #IGCS2025 is here!
The Phase 3 Hands-on Training Workshop of the IGCS Preinvasive Disease Program has commenced with great talks from faculty.
#IGCS2025
IGCS and Eisai welcomes you to view "Personalized Management of Advanced or Recurrent Endometrial Cancers: Navigating pMMR, dMMR Subtypes, or Molecular Classifications" Industry Supported Symposium presented at the IGCS 2024 Annual Global Meeting in Dublin, Ireland.
PART 1: pMMR vs dMMR Disease, Molecular Considerations in the Recurrent and First Line Setting
https://t.co/JUySee2vlh
Yet more showing the benefit of MIS. Nice retrospective analysis. Yes not RCt. But never will there be a RCT of open va MIS for 80+ year olds with endo ca! So don’t even say it
SHAPE trial results presented at #ASCO2023 supporting safety of less radical surgery in appropriately selected early stage cervical cancer patients with improved quality of life. Less is more.
MIRASOL trial
🌟453 women w FRa-pos platinum resistant OvCancer
🌟median OS 16.46 mo in Mirvetuximab arm vs 12.75 in chemo-arm,(HR)0.67,p=0.0046
🌟median PFS 5.62 mo vs 3.98,HR 0.65(p<0.0001)
🌟ORR 42.3% vs15.9%
Grade 3 TEAEs:42% vs 54% @OncoAlert https://t.co/cQIqYt044B
Fill Your Soul in Seoul at #IGCS2023!
Haneul is the Korean word for “sky.” This is a famous place for the fields of tall pampas grass, sunset views, and night views of Seoul.
https://t.co/AZNVGz5qc5
Reminder: Abstract submission is open!
"I'm a bit ashamed to admit this, but I was trying to hide the fact that I came from Lebanon."
2021 medicine laureate Ardem Patapoutian (@ardemp) shares his personal story of inclusion and how proud he is of his background (something that hasn't always been the case).
The January edition of the @RCObsGyn#TheObstetrician&Gynaecologist (TOG) has a great article and infographic on postcoital bleeding by @Wood_NJ and colleagues - see https://t.co/qNUdBbIZI0 📖